Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Exelixis is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative cancer treatments. The company focuses on therapies for challenging cancers, aiming to improve patient outcomes and quality of life. Key products include CABOMETYX® (cabozantinib) and COMETRIQ® (cabozantinib). Exelixis is driven by a commitment to scientific excellence and a patient-centric approach, continually advancing its pipeline of potential new medicines and exploring new therapeutic targets in oncology.
Serves as the central hub for corporate operations, research and development (R&D), drug discovery, clinical development, and administrative functions.
Modern laboratory and office spaces designed to foster collaboration and scientific innovation. Located in the Harbor Bay Business Park, offering a campus-like environment with waterfront views.
A dynamic, science-driven, and collaborative work environment focused on tackling challenging diseases. Employees are driven by a shared mission to make a meaningful difference in the lives of patients with cancer.
The Alameda headquarters is critical for Exelixis's strategic decision-making, scientific discovery, and overall operational management, leveraging the rich talent pool and biotech ecosystem of the Bay Area.
Exelixis's primary commercial focus is the United States. Internationally, the company extends the reach of its therapies through strategic collaborations and licensing agreements with pharmaceutical partners for development and commercialization ex-U.S. Exelixis conducts global clinical trials and maintains a growing international operational footprint to support these trials, medical affairs, and regulatory interactions in key regions like Europe.
1851 Harbor Bay Parkway
Alameda
California
USA
Address: Office space located in The Woodlands, specific street address not publicly listed.
Strategically positioned to manage and expand commercial activities and healthcare professional engagement across the United States, leveraging talent in a key Texas business hub.
Address: Dammstrasse 19, 6300 Zug, Switzerland
Provides a strategic presence in Europe, facilitating engagement with European regulatory bodies, partners, and the medical community, and supporting Exelixis's international activities and expansion efforts.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Exelixis' leadership includes:
Exelixis has been backed by several prominent investors over the years, including:
Over the past year, Exelixis has experienced key leadership changes, including the strategic appointment of a new head for Development Operations and a planned transition for the Chief Medical Officer role, reflecting ongoing evolution in its executive team.
Discover the tools Exelixis uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Exelixis commonly utilizes an email format combining the employee's first initial with their last name, followed by the @exelixis.com domain. While this is the most prevalent pattern, variations might exist within the organization.
[first_initial][last]@exelixis.com
Format
jdoe@exelixis.com
Example
90%
Success rate
Exelixis, Inc. / Business Wire • May 7, 2024
Exelixis announced its financial results for the first quarter of 2024, highlighting revenue performance from its cabozantinib franchise and outlining progress in its clinical development pipeline and corporate objectives....more
Exelixis, Inc. / Business Wire • June 3, 2024
Exelixis showcased new clinical data and trial updates for cabozantinib combinations and its pipeline assets at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, underscoring ongoing research efforts....more
Exelixis, Inc. / Business Wire • February 20, 2024
Exelixis strengthened its leadership team with the appointment of Dr. Amy Peterson to oversee its clinical development operations, leveraging her extensive experience in oncology drug development....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Exelixis, are just a search away.